Vikram Thermo (India) Limited

BSE:530477 Stock Report

Market Cap: ₹5.3b

Vikram Thermo (India) Past Earnings Performance

Past criteria checks 1/6

Vikram Thermo (India) has been growing earnings at an average annual rate of 13.7%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 18.6% per year. Vikram Thermo (India)'s return on equity is 5.3%, and it has net margins of 3.9%.

Key information

13.7%

Earnings growth rate

13.1%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate18.6%
Return on equity5.3%
Net Margin3.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Vikram Thermo (India) makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:530477 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,417561130
30 Jun 241,358411080
31 Mar 241,2642541020
31 Dec 231,2522441020
30 Sep 231,2072121210
30 Jun 231,1591831160
31 Mar 231,1151691170
31 Dec 221,0671551030
30 Sep 22984137850
30 Jun 2290997830
31 Mar 2292687820
31 Dec 2184976830
30 Sep 2185486780
30 Jun 21794105750
31 Mar 21736121720
31 Dec 20693121640
30 Sep 20626108620
30 Jun 20628104600
31 Mar 2055972590
31 Dec 1959282580
30 Sep 1960675570
30 Jun 1958853700
31 Mar 1958244580
31 Mar 1848623590
31 Mar 1745347520
31 Dec 1641850480
30 Sep 1640651450
30 Jun 1639748420
31 Mar 1638442420
31 Dec 1537333620
30 Sep 1535527600
30 Jun 1536629600
31 Mar 1537231370
31 Dec 1438737600
30 Sep 1442442600
30 Jun 1441946350
31 Mar 1443357580
31 Dec 1344170670

Quality Earnings: 530477 has a large one-off loss of ₹243.3M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 530477's current net profit margins (3.9%) are lower than last year (17.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 530477's earnings have grown by 13.7% per year over the past 5 years.

Accelerating Growth: 530477's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 530477 had negative earnings growth (-73.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.4%).

Return on Equity

High ROE: 530477's Return on Equity (5.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:41
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vikram Thermo (India) Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ashish KushwahaFirstCall Research